SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-006663
Filing Date
2024-09-24
Accepted
2024-09-24 10:07:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 40677
  Complete submission text file 0001959173-24-006663.txt   42374
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40097 | Film No.: 241317956
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GINKGO BIOWORKS, INC. 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address
Che Austin (Reporting) CIK: 0001882820 (see all company filings)

Type: 144